Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease [1]

Diabetologia

Volumn 40, Issue 12, 1997, Pages 1492-1493

  Muhlhauser, I ^a   Sawicki, P T ^a   Berger, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLIPIZIDE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; EVIDENCE BASED MEDICINE; HEART REINFARCTION; HUMAN; INSULIN TREATMENT; LETTER; MAJOR CLINICAL STUDY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH;

DIABETES MELLITUS, TYPE 2; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; SULFONYLUREA COMPOUNDS;

EID: 0031451561     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050855     Document Type: Letter

References (11)